The role of FOXC1 in clear cell ovarian carcinoma: Potential prognostic biomarker for aggressive disease?

被引：0
|
作者：
Vogel, T. J. [1 ]
Cohen, J. [1 ]
Han, B. [1 ]
Walts, A. E. [2 ]
Zhang, X. [3 ]
Karlan, B. Y. [1 ]
Cui, X. [1 ]
机构：
[1] Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 139卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2015.07.083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [31] FOXC1 Expression in Acute Myeloid Leukemia: Potential Predictor of Disease Relapse and/or Refractory Disease
    Swaminathan, Mahesh
    Jensen, Tor W.
    Ray, Tania
    Andruska, Neal D.
    Shah, Anit
    Egner, James R.
    Ray, Partha S.
    BLOOD, 2016, 128 (22)
  • [32] NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
    Chen, Jiasheng
    Ge, Jianzhang
    Zhang, Wancong
    Xie, Xuqi
    Zhong, Xiaoping
    Tang, Shijie
    FRONTIERS IN GENETICS, 2022, 13
  • [33] CDH13 is a prognostic biomarker and a potential therapeutic target for patients with clear cell renal cell carcinoma
    Shao, Yuan
    Li, Wenxia
    Zhang, Lin
    Xue, Bo
    Chen, Yongquan
    Zhang, Zikuan
    Wang, Dongwen
    Wu, Bo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (10): : 4520 - +
  • [34] Identification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma
    Lv, Qingyang
    Xiao, Wen
    Xiong, Zhiyong
    Shi, Jian
    Miao, Daojia
    Meng, Xiangui
    Yuan, Hongwei
    Yang, Hongmei
    Zhang, Xiaoping
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (11): : 1176 - 1190
  • [35] TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma
    Wang, Hongbo
    Liu, Zhendong
    Du, Yuelin
    Cheng, Xingbo
    Gao, Shanjun
    Gao, Yanzheng
    Shang, Panfeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
    Lin, Ying-Li
    Wang, Yan-Ling
    Fu, Xing-Li
    Ma, Jian-Guo
    MEDICAL SCIENCE MONITOR, 2014, 20 : 2380 - 2385
  • [37] CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
    Qihang Wu
    Cheng Fang
    Xue Wang
    Shuaishuai Huang
    Guobin Weng
    Scientific Reports, 13
  • [38] CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
    Wu, Qihang
    Fang, Cheng
    Wang, Xue
    Huang, Shuaishuai
    Weng, Guobin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [39] PROGNOSTIC VALUE OF PROGRAMMED DEATH LIGAND 1 EXPRESSION IN OVARIAN CLEAR CELL CARCINOMA
    Zhu, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1731 - 1731
  • [40] MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma
    Fang, Jiayu
    Zhen, Jing
    Gong, Yiyang
    Ke, Yun
    Fu, Bidong
    Jiang, Yike
    Xie, Jing
    Liu, Yue
    Ding, Yongqi
    Huang, Da
    Xiao, Fan
    AGING-US, 2022, 14 (18): : 7416 - 7442
12345